Cognitive Behavioral Therapy for Insomnia and Women's Health

Nowakowski, Sara; Meers, Jessica M.

doi:10.1016/j.jsmc.2019.01.002

Cited by 23 publications

(16 citation statements)

References 152 publications

(133 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, more studies on the biological or psychological mechanisms of sex differences in the sleep‐cognition linkage are warranted. Early screening and preventive intervention on late‐life insomnia, such as cognitive behavioral therapy for insomnia (CBTi), 15 might also benefit the cognitive health of female clinical populations.…”

Section: Discussionmentioning

confidence: 99%

“…Sex has been treated as a biological variable in sleep health study given of the sex differences on sleep‐related biomarker, such as hormonal change 15 . Previous study on six middle‐income countries also observed a significant sex difference on sleep patterns: males reported better sleep quality and cognitive scores, while females had longer sleep durations 16 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The role of sleep disturbances in cognitive function and depressive symptoms among community‐dwelling elderly with sleep complaints

2020

Int J Geriat Psychiatry

View full text Add to dashboard Cite

The relationships between sleep problems, cognitive impairments, and depression have been established in the aging population. However, less is known about the role of late-life onset insomnia and sex involved in these dyad or tripartite relationships. This study aimed to consider onset age of insomnia and sex in the relationship between sleep parameters, cognition and depression among older adults with current insomnia complaints. Method: A multistep sampling method was adopted to recruit participants with current insomnia complaints in China in 2018. Sleep measures include onset age of insomnia (64 years old or before vs during/after 65), three factors from insomnia severity index (ISI; nighttime, daytime, and perception), excessive daytime sleepiness, and sleep duration. Outcome measures were mini-mental state examination (MMSE) and center for epidemiologic studies depression scale (CESD). Results: The average age of older adults was 75 (SD = 7.1). Among them, 62% participants are female. In general, older aged, female, late-life onset insomnia as well as interaction of sex * onset age of insomnia were significantly associated with poorer cognition. Yet, age, sex, and onset age of insomnia were not significant indicators for depression. For female participants, later onset of insomnia, nighttime symptoms of insomnia, excessive daytime sleepiness and depression were risk factors for cognitive decline. Nevertheless, only daytime sleepiness, together with depression, were found positively associated with male participants' cognitive decline. Conclusions: There were robust associations between daytime sleepiness, depressive symptoms, and poor cognitive performance. More importantly, late-life onset insomnia was particularly indicative for poor cognitive performance among female older adults. Future study should emphasize the specific mechanism involved in changes of sleep patterns in the development of cognitive impairment among older adults. Sex differences in the relationship between onset age of insomnia and cognition also require further attention.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The role of sleep disturbances in cognitive function and depressive symptoms among community‐dwelling elderly with sleep complaints

2020

Int J Geriat Psychiatry

View full text Add to dashboard Cite

show abstract

“…For example, owing to hormonal, anatomic, and physiological changes, pregnant women tend to experience sleep disturbances and insomnia more frequently than the general population. 91 Since patients and prescribers are likely to have concerns about the use of sleep medication in women who are pregnant or breastfeeding, CBT-I may be a more appropriate and preferred intervention for insomnia during pregnancy and the postpartum period. 91 , 92 In a randomized, unmasked, controlled trial comparing CBT-I to control insomnia therapy (modified pseudodesensitization therapy for insomnia) in women with insomnia disorder between 18 and 32 weeks of pregnancy, CBT-I was associated with significantly faster remission of insomnia.…”

Section: Introductionmentioning

confidence: 99%

“… 91 Since patients and prescribers are likely to have concerns about the use of sleep medication in women who are pregnant or breastfeeding, CBT-I may be a more appropriate and preferred intervention for insomnia during pregnancy and the postpartum period. 91 , 92 In a randomized, unmasked, controlled trial comparing CBT-I to control insomnia therapy (modified pseudodesensitization therapy for insomnia) in women with insomnia disorder between 18 and 32 weeks of pregnancy, CBT-I was associated with significantly faster remission of insomnia. In addition, significantly greater improvements in insomnia severity, total wake time, and Edinburgh Postnatal Depression Scale scores versus control therapy ( p <0.01 for all) were also observed.…”

Section: Introductionmentioning

confidence: 99%

Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies

Rosenberg¹,

Citrome²,

Drake³

2021

NDT

View full text Add to dashboard Cite

Chronic insomnia disorder, which affects 6–10% of the population, is diagnostically characterized by ongoing difficulties with initiating or maintaining sleep occurring at least three times per week, persisting for at least 3 months, and associated with daytime impairment. While chronic insomnia is often considered a condition primarily related to impaired sleep, the disorder can also adversely affect domains of physical and mental health, quality of life, and daytime function, which highlights the importance of treating the multidimensional sleep disorder. Owing to misperceptions about the safety and effectiveness of treatment options, many individuals with insomnia may not seek professional treatment, and alternatively use ineffective home remedies or over-the-counter medications to improve sleep. Some physicians may even believe that insomnia is remediated by simply having the patient “get more sleep”. Unfortunately, treatment of insomnia is not always that simple. The disorder’s complex underlying pathophysiology warrants consideration of different nonpharmacologic and pharmacologic treatment options. Indeed, recent insights gained from research into the pathophysiology of insomnia have facilitated development of newer treatment approaches with more efficacious outcomes. This narrative review provides a summary of the diagnostic criteria and pathophysiology of insomnia and its subtypes. Further, this review emphasizes new and emerging nonpharmacologic and pharmacologic treatments for chronic insomnia, including recent enhancements in approaches to cognitive behavioral therapy for insomnia (CBT-I) and the new dual orexin receptor antagonist (DORA) pharmacologics. These advances in treatment have expanded the treatment options and are likely to result in improved outcomes in patients with chronic insomnia.

show abstract

“…EA can modulate brain activity via a needling/ tactile somatosensory specific stimulus, which may regulate the sleep and wakefulness (Napadow et al., 2012). However, studies have identified gender as a factor influencing the clinical treatment efficacy of some treatments for insomnia (Nowakowski and Meers 2019). We would like to know whether there is a gender‐related difference in the treatment efficacy of EA for PI and the possible causes for it.…”

Section: Introductionmentioning

confidence: 99%

Gender‐related difference in altered fractional amplitude of low‐frequency fluctuations after electroacupuncture on primary insomnia patients: A resting‐state fMRI study

Shi

Wang

et al. 2020

Brain and Behavior

View full text Add to dashboard Cite

show abstract

Cognitive Behavioral Therapy for Insomnia and Women's Health

Cited by 23 publications

References 152 publications

The role of sleep disturbances in cognitive function and depressive symptoms among community‐dwelling elderly with sleep complaints

The role of sleep disturbances in cognitive function and depressive symptoms among community‐dwelling elderly with sleep complaints

Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies

Gender‐related difference in altered fractional amplitude of low‐frequency fluctuations after electroacupuncture on primary insomnia patients: A resting‐state fMRI study

Contact Info

Product

Resources

About